Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer's disease with real-world clinical validation
Open accessPublished version of a preprint
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Drug repurposing represents an attractive alternative to the costly and time-consuming process of new drug development, particularly for serious, widespread conditions with limited effective treatments, such as Alzheimer’s disease (AD). Emerging generative artificial intelligence (GAI) technologies like ChatGPT offer the promise of expediting the review and summary of scientific knowledge. To examine the feasibility of using GAI for identifying drug repurposing candidates, we iteratively tasked ChatGPT with proposing the twenty most promising drugs for repurposing in AD, and tested the top ten for risk of incident AD in exposed and unexposed individuals over age 65 in two large clinical datasets: (1) Vanderbilt University Medical Center and (2) the All of Us Research Program. Among the candidates suggested by ChatGPT, metformin, simvastatin, and losartan were associated with lower AD risk in meta-analysis. These findings suggest GAI technologies can assimilate scientific insights from an extensive Internet-based search space, helping to prioritize drug repurposing candidates and facilitate the treatment of diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A recent study employed GPT-4 to generate and prioritize potential AD therapeutics, followed by retrospective validation in two large-scale electronic health record cohorts from Vanderbilt University and the All of Us Research Program. Metformin, simvastatin, and losartan were each associated with reduced AD incidence after adjusting for confounders, highlighting the utility of generative models”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [360]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug repurposing: progress, challenges and recommendations
Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.168 · Cited by 4,718
MatchIt : Nonparametric Preprocessing for Parametric Causal Inference
Ho, D. E., Imai, K., King, G., & Stuart, E. A. (2011) · Journal of Statistical Software · doi:10.18637/jss.v042.i08 · Cited by 4,385 · cited 1×
“PS matching was performed using the MatchIt R package 36 .”
Kung, T. H., Cheatham, M., Medenilla, A., Sillos, C., De Leon, L., Elepaño, C., Madriaga, M., Aggabao, R., Diaz-Candido, G., Maningo, J., et al. (2023) · PLOS Digital Health · doi:10.1371/journal.pdig.0000198 · Cited by 4,115
Kung, T. H., Cheatham, M., ChatGPT, Medenilla, A., Sillos, C., De Leon, L., Elepaño, C., Madriaga, M., Aggabao, R., Diaz-Candido, G., et al. (2022) · doi:10.1101/2022.12.19.22283643 · Cited by 4,115
Large language models encode clinical knowledge
Singhal, K., Azizi, S., Tu, T., Mahdavi, S. S., Wei, J., Chung, H. W., Scales, N., Tanwani, A., Cole-Lewis, H., Pfohl, S., et al. (2023) · Nature · doi:10.1038/s41586-023-06291-2 · Cited by 4,083 · cited 1×
“subsequent optimization of responses that display reasoning processes 4,5 .”
Large Language Models Encode Clinical Knowledge
Singhal, K., Azizi, S., Tu, T., Mahdavi, S. S., Wei, J., Chung, H. W., Scales, N., Tanwani, A., Cole-Lewis, H., Pfohl, S., et al. (2022) · arXiv · doi:10.48550/arxiv.2212.13138 · Cited by 4,083
Ayers, J. W., Poliak, A., Dredze, M., Leas, E. C., Zhu, Z., Kelley, J. B., Faix, D. J., Goodman, A. M., Longhurst, C. A., Hogarth, M., et al. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.1838 · Cited by 2,613
The “All of Us” Research Program
The All of Us Research Program Investigators (2019) · New England Journal of Medicine · doi:10.1056/nejmsr1809937 · Cited by 2,440
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine
Lee, P., Bubeck, S., & Petro, J. (2023) · New England Journal of Medicine · doi:10.1056/nejmsr2214184 · Cited by 1,738
MatchIt: Nonparametric Preprocessing for Parametric Causal Inference
Ho, D., Imai, K., King, G., Stuart, E., & Greifer, N. (2005) · CRAN: Contributed Packages · doi:10.32614/cran.package.matchit · Cited by 1,206
Cited by
Alzheimer’s Disease: Exploring the Landscape of Cognitive Decline
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00339 · Cited by 170
Scherbakov, D., Hubig, N., Jansari, V., Bakumenko, A., & Lenert, L. A. (2024) · arXiv · doi:10.48550/arxiv.2409.04600 · Cited by 156
Scherbakov, D., Hubig, N., Jansari, V., Bakumenko, A., & Lenert, L. A. (2025) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaf063 · Cited by 154
Applications of Artificial Intelligence in Drug Repurposing
Wan, Z., Sun, X., Li, Y., Chu, T., Hao, X., Cao, Y., & Zhang, P. (2025) · Advanced Science · doi:10.1002/advs.202411325 · Cited by 126
Ng, K. K. Y., Matsuba, I., & Zhang, P. C. (2025) · NEJM AI · doi:10.1056/aira2400380 · Cited by 107
Metadata
- Authors
- Yan, C., Grabowska, M. E., Dickson, A. L., Li, B., Wen, Z., Roden, D. M., Michael Stein, C., Embí, P. J., Peterson, J. F., Feng, Q., Malin, B. A., & Wei, W.-Q.
- Affiliations
- Vanderbilt University Medical Center (US)
- Vanderbilt University (US)
- Emory University (US)
- Corresponding author
- Wei, Wei-Qi
- ORCID
- Venue
- npj Digital Medicine
- Published
- 2024-02-26
- Volume
- 7
- Issue
- 1
- Pages
- 46-46
- ISSN
- 2398-6352 (ISSN-L)
- PMC
- PMC10897392
- OpenAlex
- W4392162026
- Cited by
- 73
- References
- 40
- Citations by year
- 2026: 23 · 2025: 37 · 2024: 13
- FWCI
- 20.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- npj Digital Medicine (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG069900, F30AG080885)
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM139891, R35GM131770)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- drug repurposing, Alzheimer's disease, generative AI, ChatGPT, candidate prioritization, metformin, simvastatin, losartan, older adults, real-world clinical data, All of Us
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer's disease with real-world clinical validation. https://app.cochat.ai/papers/10.1038/s41746-024-01038-3
- The paper
- Yan, C., Grabowska, M. E., Dickson, A. L., Li, B., Wen, Z., Roden, D. M., Michael Stein, C., Embí, P. J., Peterson, J. F., Feng, Q., Malin, B. A., & Wei, W.-Q. (2024). Leveraging generative AI to prioritize drug repurposing candidates for Alzheimer's disease with real-world clinical validation. npj Digital Medicine. https://doi.org/10.1038/s41746-024-01038-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.